Nuvation Bio Inc. (NUVB) Balance Sheet
As of 2026-06-30 (10-Q), Nuvation Bio Inc. (NUVB) reported total assets of $744.5M, total liabilities of $490.6M and shareholders' equity of $253.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $258.6M. Long-term debt: $242.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NUVBNuvation Bio Inc.Follow NUVB — free
—
Price chart with a free account
- Market cap
- 1.6B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 29.8 | 132.4 | 101.1 | 42.6 | 35.7 | 164.1 | 258.6 | |
| Short-term investments | 186.0 | 633.0 | 559.9 | 568.6 | 467.0 | 365.1 | 402.4 | |
| Inventory | — | — | — | — | 0.0 | 11.4 | 19.9 | |
| Current assets | 220.7 | 772.1 | 667.3 | 616.4 | 526.3 | 571.5 | 726.4 | |
| Total assets | 221.8 | 776.2 | 672.1 | 621.5 | 540.6 | 594.8 | 744.5 | |
| Current liabilities | 6.6 | 16.9 | 13.2 | 14.0 | 58.2 | 82.2 | 86.8 | |
| Long-term debt | — | — | — | — | — | 47.2 | 242.6 | |
| Short-term debt | — | — | — | 0.0 | 6.3 | 5.7 | 5.9 | |
| Total liabilities | 6.7 | 30.2 | 17.1 | 16.4 | 76.8 | 289.1 | 490.6 | |
| Shareholders' equity | 215.1 | 746.0 | 655.1 | 605.1 | 463.8 | 305.7 | 253.9 |
USD millions · SEC XBRL
Nuvation Bio Inc. — questions
- How much cash does Nuvation Bio Inc. have?
- $258.6M in cash and cash equivalents as of 2026-06-30.
- How much debt does Nuvation Bio Inc. have?
- $242.6M of long-term debt and $5.9M due within a year as of 2026-06-30.
- What are Nuvation Bio Inc.'s total assets?
- $744.5M as of 2026-06-30.
- What is Nuvation Bio Inc.'s shareholders' equity?
- $253.9M as of 2026-06-30.
Every figure on this page comes from Nuvation Bio Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.